Prove design control, production quality, and post-market vigilance across the device lifecycle.
QMS for medical devices across the full lifecycle: design and development, purchasing, production, installation, servicing, storage, distribution, and decommissioning.
Disciplined design and development with complete design history files, technical documentation, verification and validation records.
Risk management integration and traceability to requirements and tests throughout the device lifecycle.
Sterile device controls and cleanroom management where applicable to device classification and manufacturing.
Comprehensive supplier control and outsourced process management with qualification and ongoing evaluation.
Unique device identification, labeling control, instructions for use management, complaint handling, and CAPA.
Post-market surveillance, feedback, vigilance, trending, and improvement (Clause 8) for continuous monitoring.
OEMs and legal manufacturers responsible for design, production, and post-market activities.
Critical suppliers, sterilization providers, and packaging companies in the device supply chain.
Distribution and service organizations where applicable to their role in device lifecycle.
Applies to all device classes (I, IIa, IIb, III). Higher classes add depth and rigor, not different fundamentals.
Key differences that make ISO 13485 specifically suited for medical device regulatory environments.
General quality management for customer satisfaction and continuous improvement
Regulatory purpose — prioritizing risk, documentation, and process control over generic improvement
Basic design and development requirements
Prescriptive design control records, verification/validation traceability, and device file requirements
Risk-based thinking encouraged
Risk management embedded throughout realization and post-market surveillance — pairs with ISO 14971
Flexible documentation approach
Extensive documented information requirements for regulatory compliance and traceability
Customer feedback and satisfaction monitoring
Comprehensive post-market surveillance, vigilance reporting, and feedback systems (Clause 8)
ISO 13485 alignment with major regulatory frameworks worldwide.
FDA replaced the QSR with the Quality Management System Regulation (QMSR), harmonized to ISO 13485:2016. Enforcement starts February 2, 2026.
Certification to ISO 13485 is not itself required by FDA, but compliance must be aligned to QMSR requirements.
ISO 13485 supports EU MDR QMS expectations but MDR imposes additional requirements for clinical evaluation, post-market surveillance, and vigilance.
Use ISO 13485 as the QMS backbone and map MDR Article 10.9 processes for complete compliance.
Current state analysis, gap identification, resource planning, and project setup.
Policy creation, procedure development, template deployment, and initial training.
Process validation, software validation, supplier qualification, and system testing.
Internal audits, management review, CAPA closure, and certification audit preparation.
Typical range: 16–28 weeks for single-site SME with existing controls; large/multi-site often 6–12 months.
Software as a Medical Device (SaMD), Class III devices, sterile manufacturing, multiple sites, extensive supplier networks, legacy design history files.
Class IIa/IIb devices, cleanroom operations, moderate design activity, established supplier base, single manufacturing site.
Class I devices, limited design activity, contract manufacturing only, well-established processes, single product line.
Comprehensive deliverable package for ISO 13485 implementation and certification readiness.
Full preparation for FDA QMSR inspections and EU MDR compliance audits with documented QMS alignment.
Global customer recognition of ISO 13485-conformant QMS, supporting notified body approvals and international sales.
Design right-first-time, validated processes, superior supplier quality, fewer complaints and recalls.
Clean design history files and technical documentation accelerate regulatory submission and approval processes.
Integrated risk management throughout device lifecycle reduces liability and improves patient safety outcomes.
Third-party validated QMS provides competitive differentiation and customer confidence in quality systems.
Comprehensive training pathway from awareness to expert-level auditing capabilities.
Introduction to ISO 13485 requirements, medical device QMS fundamentals, and regulatory context for all staff.
ISO 19011-based internal auditing skills specific to medical device QMS and regulatory requirements.
Advanced implementation skills for QMS development, design controls, and regulatory compliance management.
CQI/IRCA certified lead auditor course for certification body auditing and third-party assessment capabilities.
Advanced workshop on design controls, DHF management, V&V protocols, and design transfer.
Hands-on workshop for risk management file development and ISO 13485 integration.
Software as Medical Device lifecycle, computer system validation, and cybersecurity considerations.
Post-market surveillance program design, vigilance reporting, and trend analysis techniques.
No. ISO 13485 embeds risk management requirements throughout the standard, but ISO 14971 defines the specific device risk management process and Risk Management File structure. Both standards work together — use ISO 13485 as the QMS framework and ISO 14971 for the risk management methodology.
FDA’s QMSR (effective Feb 2, 2026) is harmonized to ISO 13485:2016. While FDA does not require ISO 13485 certification, compliance must meet QMSR requirements which align with ISO 13485. Certification provides strong evidence of QMSR compliance during FDA inspections.
ISO 13485 provides the quality management system backbone required by EU MDR Article 10.9. However, MDR adds specific requirements for clinical evaluation, post-market clinical follow-up, and enhanced vigilance that must be mapped and implemented beyond ISO 13485 requirements.
ISO 13485 Clause 8 requires comprehensive post-market surveillance including feedback systems, complaint handling, trending, and improvement. This aligns with FDA post-market requirements and provides the foundation for EU MDR post-market surveillance and vigilance reporting.
ISO 13485 follows a standard 3-year certification cycle with annual surveillance audits. Initial certification includes Stage 1 (document review) and Stage 2 (implementation audit). Surveillance audits occur at 12 and 24 months, with full recertification at 36 months.
Get started with our comprehensive ISO 13485 implementation and certification support designed specifically for medical device companies.
Comprehensive evaluation of your current QMS against ISO 13485 requirements with detailed implementation roadmap.
Get Gap AssessmentDevelop internal competency with our medical device-specific internal auditor certification program.
Book TrainingPre-certification audit simulation to ensure readiness and identify any final gaps before formal assessment.
Request Mock AuditQuestions about ISO 13485 implementation for your medical device company?
Talk to Our Medical Device Experts